Nebivolol Hydrochloride API

Name	Nebivolol Hydrochloride
Chinese name	盐酸奈必洛尔
Cas Number	152520-56-4
Source	India
Qualifications	USDMF/-/-/-/-

It was listed in Germany for the first time in May 1997. The original research was Menarini, Italy, and it has been listed for sale in many countries around the world. Compared with similar drugs on the market, it has fewer adverse reactions and unique pharmacological effects. It is a selective β-receptor blocker with vasodilator effect. It is used for the treatment of patients with mild to moderate hypertension. It can also be used For the treatment of angina pectoris and congestive heart failure. As a third-generation β-receptor antagonist, Nebivolol is a potent and selective third-generation β-receptor blocker, blocking β1 receptors 290 times stronger than β2 receptors, while peso Lolol was 26 times, atenolol was 15 times, and propranolol was 1.9 times. Therefore, this product has higher selectivity, does not cause bronchial smooth muscle and vascular smooth muscle contraction, and has no endogenous sympathomimetic activity. It has the advantages of protecting the heart, good antihypertensive effect, good tolerance and few adverse reactions. Nebivolol can be used for a long time, and it can maintain the antihypertensive effect after 3 years of continuous use. It will not reduce the effect due to drug tolerance. Therefore, the market prospect is broad and the potential is huge.

Hot Tags: nebivolol hydrochloride api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Edoxaban API, Temozolomide API, Celecoxib API, Cinacalcet Hydrochloride API, Dapoxetine API, Itraconazole Hydrochloride API

• Previous: Methylprednisolone Acetate API
• Next: Fexofenadine Hydrochloride API